Benjamin Strobel
Birkendorfer Str. 65
Biberach An Der Riss, BW 88397, Germany
Biberach An Der Riss, BW 88397, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathy.
Journal: Molecular therapy. Advances
Published: February 23, 2026
Deep-sequencing-guided library screening and profiling of AAV capsids in the primate retina.
Journal: Molecular therapy. Advances
Published: November 12, 2025
Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA in situ hybridization.
Journal: Molecular therapy. Advances
Published: September 26, 2025
Glucagon controls obesity-specific energy expenditure via persistent cAMP/PKA signaling.
Journal: Journal of hepatology
Published: February 20, 2025
AAV yield, bioactivity, and particle heterogeneity are impacted by genome size and non-coding DNA elements.
Journal: Molecular therapy. Methods & clinical development
Published: January 17, 2025
Mapping administration route-dependent transduction profiles of commonly used AAV variants in mice by barcode amplicon sequencing.
Journal: Molecular therapy. Methods & clinical development
Published: January 07, 2025
MicroRNA-based targeting strategies enable AAV-mediated, tissue-selective gene expression in adipose tissue and skeletal muscle of mice.
Journal: Molecular therapy. Advances
Published: September 29, 2024
Longitudinal Associations Between MicroRNAs and Weight in the Diabetes Prevention Program.
Journal: bioRxiv : the preprint server for biology
Published: June 19, 2024
JUNB O-GlcNAcylation-Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 18, 2024
Suppression of toxic transgene expression by optimized artificial miRNAs increases AAV vector yields in HEK-293 cells.
Journal: Molecular therapy. Methods & clinical development
Published: February 19, 2024
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice.
Journal: Frontiers in immunology
Published: December 22, 2023
Last Updated: 09/26/2026